---
schema_version: "secwatch.filing_event.v1"
accession: "0001793229-25-000106"
form_type: "8-K"
ticker: "CTEV"
cik: "0001793229"
company_name: "Claritev Corp"
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T05:10:30.789358+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Claritev Q1 revenue $231.3M (-1.4% YoY); net loss $71.3M vs $539.7M; reaffirms FY guidance

## Summary
- Revenue $231.3M, down 1.4% from $234.5M; net loss improved to $71.3M from $539.7M.
- Adjusted EBITDA $142.1M (61.4% margin) vs $146.8M in prior year.
- Free cash flow negative $(68.9)M vs positive $19.2M; cash $23.1M.
- Reaffirmed FY2025 guidance: revenue (2)% to flat, Adj. EBITDA margin 62.5%-63.5%, FCF $(65)-$(75)M.
- Announced strategic alliances with Oracle, J2 Health, and Burjeel Holdings; new Chief Medical and AI officers.

## SEC filing metadata
- accession: 0001793229-25-000106
- form_type: 8-K
- ticker: CTEV
- cik: 0001793229
- company_name: Claritev Corp
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1793229/000179322925000106/0001793229-25-000106-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1793229/000179322925000106/ctev-20250508.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001793229-25-000106
- JSON: https://secwatch.observer/filing/0001793229-25-000106.json
- Plain text: https://secwatch.observer/filing/0001793229-25-000106.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.